Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells. by Péault, B et al.
UCSF
UC San Francisco Previously Published Works
Title
Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor 
cells.
Permalink
https://escholarship.org/uc/item/409806gj
Journal
The Journal of experimental medicine, 174(5)
ISSN
0022-1007
Authors
Péault, B
Weissman, IL
Baum, C
et al.
Publication Date
1991-11-01
DOI
10.1084/jem.174.5.1283
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Bries Deflnltive Report 
Lymphoid Reconstitution of the Human Fetal 
Thymus in SCID Mice with CD34 + Precursor Cells 
By Bruno P6ault, Irving L. Weissman,* Charles Baum, 
Joseph M. McCune, and Ann Tsukamoto 
From SyStemix, Ina, Palo Alto, California 94303; and the *Howard Hughes Institute, 
Beckman Center for Molecular and Genetic Medicine, Stanford University School of Medicine, 
Stanford, California 94305 
StlmmA.l~ 
The search for human hematopoietic stem ceils has been hampered by the lack of appropriate 
assay systems. Demonstration of the ability of precursor cell candidates to give rise to T cells 
is of significant difficulty since dissociated in vitro cultured thymus troma cells lose their ability 
to sustain thymocyte maturation. To define further the differentiative capacities of the rare human 
fetal liver and bone marrow cells that express the CD34 surface antigen and exhibit in vitro 
myeloid and pre-B cell activities, we have microinjected them into HLA-mismatched fetal thymus 
fragments, partially depleted of hematopoietic cells by low temperature culture. In vitro colonized 
thymuses have then been allowed to develop upon engraftment i to immunodeficient SCID mice. 
Using this modification of the SCID-hu system, we show that low numbers of fetal CD34 + 
progenitor cells can repopulate the lymphoid compartment in the human thymus. 
T he production of hematopoietic cells in blood-forming organs requires interactions between progenitor cells and 
stromal elements that can be, in some instances, experimen- 
tally reproduced in vitro. Bone marrow cells, cultured in a 
two-dimensional arrangement, retain their ability to support 
myelopoiesis and B lymphocyte production, yielding con- 
venient in vitro stem cell assays in both murine (see reference 
1 for a review) and human (2; Bantu, C., and A. Tsukamoto, 
manuscript submitted for publication) models. In contrast, 
the maintenance of the three-dimensional structure of thymic 
reticulum appears to be a prerequisite for driving the full 
differentiation of stem cells into mature T lymphocytes. In
the mouse, experimental T cell differentiation can be achieved 
in a quantitative manner by transfer of precursor cell candi- 
dates into irradiated hosts, either systemically (3) or by direct 
intrathymic njection (4, 5). Similar physiologic assays of puta- 
tive T cell precursors in man are, of course, impossible. The 
SCID-hu mouse, a chimera obtained by transplantation f 
human hematolymphoid t ssue into a congenitally immuno- 
deficient host, may provide an in vivo culture system for dis- 
secting the human T ceil differentiation process (6). In this 
study, we have first colonized lymphocyte-depleted human 
thymus fragments in vitro by HLA-mismatched putative 
precursor cells, then transplanted them into C.B.17 scid/scid 
(SCID) mice to facilitate xpansion and differentiation fthe 
donor cell population. The candidate hematopoietic precursor 
calls we have first analyzed in this experimental system ex- 
press the CD34 surface antigen and represent "~1-4% of bone 
marrow and fetal liver cells. CD34 + cells can be shown to 
include colony-forming units endowed with myeloid (7-9) 
and pre-B cell activity (Baum, C., and A. Tsukamoto, manu- 
script submitted for publication); they also give rise to colo- 
nies of blast cells on bone marrow stroma capable of self 
renewal and multilineage commitment (10). These observa- 
tions suggest hat the CD34 + cell pool may include mul- 
tipotential stem cells. 
Materials and Methods 
Hematopoietic Depletion and Reconstitution f the Human Fetal 
hymus. Individual lobules from 19-22-wk fetal thymuses obtained 
om elective abortions were placed on sterile nitrocellulose filter 
squares (1 cmx 1 cm) (Millipore Corp., Bedford, MA) supported 
by absorbent gelatin sponges (Gelfoam; UpJohn, Kalamazoo, MI), 
in 3.5-cm petri dishes containing 2 ml of RPMI, 10% heat- 
inactivated FCS, and penicillin/streptomycin, for 7 d at 25~ in 
a 5% CO2 atmosphere. An oil-filled syringe (Hamilton Co., 
Keno, NV) with a screw-operated plunger was used to inject, 
through glass micropipettes, uspensions (0.5-1 #1) of HLA- 
mismatched CD34 + or CD34- cells into low temperature-cul- 
tured thymus fragments. Invitro colonized thymus fragments were 
inserted under the kidney capsule of Nembutal-anesthetized CB17 
scid/scid mice bred in our own facility. 
Sorting of Hematopoietic Precursor Cells from Human Fetal Blood- 
,forming Organs. Human fetal marrow cell suspensions were pre- 
pared from long bones of 15-20-wk-fetuses. The bones were split 
lengthwise, then placed in a 1-mg/ml solution of collagenase/dis- 
pase in RPMI 1640 for 30 rain at 37~ after which time the medul- 
lary cavity was flushed with medium (RPMI 1640 with Pen/Strep, 
2-ME, and 10% FCS) to remove hematopoietic cells. Red blood 
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cells were lysed by low osmolarity ammonium chloride treatment. 
Cell suspensions were mechanically prepared from livers of 14-20- 
wk fetuses, then placed on a Ficoll-Hypaque gradient (Sigma Chem- co 
ical Co., St. Louis, MO) to remove hepatocytes, red blood cells, W 
and debris, ef c2~ 
CD34 § and CD34- cells were isolated on a FACStar | (Becton O 
Dickinson & Co., Mountain View, CA) from fresh fetal iver or 
bone marrow mononucleated cell suspensions, after labeling with 
a monodonal nti-CD34 IgM (kindly provided by Dr. Irving Bern- 
stein, Fred Hutchinson Cancer Center, Seattle, WA), then with 
a goat antibody anti-mouse IgM, non-crossreactive o human Igs, 
conjugated toPE or to FITC (Caltag Labs., South San Francisco, co ff  
) 
CAA'nalysis of T Cell Repopulation i  Human Fetal Thymus Grafts. 0 For analysis of chimerism, mice were killed by cervical dislocation 
and human thymus grafts dissected free of kidney tissue. Tbymo- 
cytes were then mechanically dispersed and stained by two-color 
immunofluorescence, resuspended in the presence ofpropidium io- 
dide, and analyzed on a FACScan | (Becton Dickinson & Co.). PE- 
labeled anti-CD3, anti-CD4, and anti-CD8 mAbs were purchased oo 
from Becton Dickinson & Co. Hybridomas secreting the following W 
anti-MHC class I antibodies: BB7.2 (anti-A2), MA2.1 (anti-A2 and D 
B17), GAPA3 (anti-A3), W632 (anti-A, B, C), BB7.1 (anti-BT), O 
and MB40.2 (anti-B7 and B40) were obtained from the American 
Type Culture Collection (Rockville, MD). mAbs were purified from 
ascitic fluids and directly labeled with FITC. 
lmmunohistochemical An ysis of CD34 + Cell.reconstituted Human 
Fetal Thymus Grafts. 6-/zm cryostat sections of frozen grafts were 
air-dried and fixed with acetone. Rehydrated sections were incubated 
successively with mouse monoclonal nti-human class I antibody, 
biotinylated-horse anti-mouse Ig antibody (Vector Labs., Inc., 
Burlingame, CA), and avidin-alkaline phosphatase at room tem- 
perature. For development, a mixture of Fast Blue BB salt (2.5 g 
in 50/zl dimethylformamide) andnaphtol AS phosphate (2.5 mg 
in 50 #1 dimethylformamide) was used, in 2.5 ml of 0.05 M 
propanediol buffer, pH 9.75, containing 60/zl of 10 mM levami- 
sole to block endogenous enzyme activity. Sections were then post- 
fixed with 20% formalin for 5 rain, washed in distilled water, coun- 
terstained with hematoxylin, and mounted in gelatin-glycerol. 
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Figure 1. Lymphoid reconsti- 
tution of the 20-wk human fetal 
thymus after in vitro intrathymic 
transfer of 104 fetal bone marrow 
(22 wk) CD34 + cells and en- 
graftment i o SCID mice for (.4) 
I mo, (B) 6 wk, and (C) 4.5 mo. 
(D) Surface HLA class I antigen 
distribution i a cell suspension 
from a fresh 19-wk fetal thymus. 
lhsults and Discussion 
Reducing the size of the thymus hematopoietic cell com- 
partment isa prerequisite oexperimental reconstitution a d 
can be achieved by low temperature in vitro organ culture 
(11). Human thymus tissue cultured at 25~ appeared as a 
loose epithelial network, showing large lymphocyte-free ar as 
(not shown), as previously described in the mouse model (11). 
HLA-mismatched CD34 + or CD34- cell suspensions sorted 
from fresh human fetal iver or bone marrow were delivered 
by microinjection to the depleted thymus pieces. After en- 
graftment under the kidney capsule of SCID mice, low tem- 
perature-cultured, in vitro colonized thymus fragments were 
vascularized and grew. At intervals, grafts were harvested, 
reduced into cell suspensions, and analyzed for chimerism 
in the T cell compartment. Using a two-color immunofluores- 
cence assay class I HLA antigens served as markers for donor 
vs. host-derived lymphocytes. The initial phase of thymus 
lymphoid repopulation from injected onor cells was difticult 
to trace given the fact that nonmature and immature cortical 
thymocytes xpress very low quantities of class I antigens. 
Chimerism could be evidenced when the progeny of trans- 
ferred cells was differentiated far enough to express detect- 
able amounts of class I molecules, which occurred 3-4 wk 
after the engraftment of thymus colonized with 104 CD34 + 
cells (Fig. 1 A). From this time onwards, the donor-derived 
population was observed to expand and mature, with larger 
numbers of thymocytes in the graft expressing higher amounts 
of the donor class I antigens. After 6 wk, the donor-derived 
thymocyte population in the graft was similar to that of a 
fresh normal thymus, with respect o its range of CL I an- 
tigen expression (Fig. 1, B and D). Eventually, the progeny 
of the transferred CD34 § cells appeared as populations of 
mature-type T lymphocytes, expressing high levels of class 
I antigens (Figs. 1 C and 2, A-C). These cells were analyzed 
by three-color immunofluorescence andfound to include, in 
the expected proportions, donor-derived lements that were 
either CD4 + or CD8 + (not shown). In contrast, no T cell 
repopulation was ever observed after transfer of fetal iver or 
bone marrow CD34- counterpart cells, which were ana- 
lyzed in the same conditions in all experiments. The successful 
1284 Stem Cell-mediated Experimental Human Thymopoiesis 
{30 
W 
rm 
(..) 
130 
W 
E] 
O 
CO ,,q- 
rm 
O 
CO 
O 
Prob 
1 04 / J ~  
3b ~' ,.; : (- ,,%, $~Y 
10 '-~, ~', ~ 
102 j .:, 
1011 -, 0 
1 00/~'~ 
! 
103~ .. ~ -~ 
102 I ?~ 
101- ~.~ '  
100 ~/  
104 [ 
104 
103~,~ :) 
1021~:~ 
1011/"i: 
100 /  , 
10 0 101 
Donor  HLA class ] 
Prob 
A 
i'0 2 1'03 104 100 101 102 1~03 104 
Host HLA ciass I 
Figure 2. T cell reconstitution in the human fetal thymus after in vitro 
intrathymic transfer of (A) 104, (B) 103, (C) 103 CD34 + cells sorted from 
fetal liver, and engraftment for 3 mo into SCID mice. As a control, D 
shows a case of unsuccessful reconstitution f llowing transfer of 103 cells. 
The thymus was 21 wk old and CD34 § cells were sorted from a 14.5- 
wk liver. 
engraftment and differentiation of 104 CD34 + cells prompted 
an attempt to repopulate the thymus with lower numbers 
of these precursors. As shown in Fig. 2, complete T cell 
repopulation was observed after supplying the thymus with 
103 and even 102 CD34 + cells, the lowest number assayed 
SO ~ar. 
To visualize the tissue distribution of the cells generated 
by the microinjected precursor cell population, sections from 
thymus grafts fully reconstituted with 103 CD34 + cells were 
stained with mAbs specific for either host or donor class I 
HLA antigens. Host class I molecules were restricted to pi- 
thelial cells in the cortex and at the corticomedullary junc- 
tion, and of cells with a dendritic morphology in the medulla 
where, by contrast, no stained lymphocytes were present (Fig. 
3). The donor-specific anti-class I reagent stained almost ex- 
clusively packed lymphocytes in the medullary region. 
Whether cortical thymocytes were all donor derived or in- 
cluded resurgent host cells could not be determined in the 
present experimental system. 
These results show that at least a fraction of the CD34 + 
cell population present in the fetal liver and bone marrow 
has the ability to differentiate into thymic lymphocytes when 
experimentally introduced into the thymic microenvironment. 
Figure 3. Immunohistochemical analysis of human fetal thymus hema- 
topoietic reconstitution after in vitro transfer of 10 a fetal bone marrow 
CD34 § cells and 4-mo engraftment in a SCID mouse. (A) Staining by 
host-specific anti-class I antibody. Epithelial cells in the cortex and medulla 
are stained. The medullary region, identifiable by the presence of Hassall's 
corpuscles (/4), is devoid of labeled iymphocytes but contains dendritic- 
like cells of host origin. (B) Staining by donor-specific anti-class 1 anti- 
body is mostly restricted to densely packed medullary lymphocytes. (C) 
Staining by a monomorphic anti-class I antibody restores the cortical and 
medullary class I antigen distribution of a normal thymus. 
Human CD34 § cells are phenotypically heterogenous and
can be subdivided into several subsets coexpressing, among 
others, the myeloid-specific CD33, B cell-specific CD19 and 
CD10, and T cell-restricted CD7 lineage markers. Interest- 
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ingly, human in vitro colony-forming cells can be distinguished 
from their precursors ince only the former express CD33, 
whereas all of them are CD34 + (12). CD7 is believed to be 
expressed by extrathymic pre-T cells (13, 14). The above- 
described thymic reconstitution assay should allow the defini- 
tion of the subsets of human bone marrow cells that can give 
rise to thymic colonization and T cell differentiation, using 
techniques that defined at least two subsets of mouse bone 
marrow cells with this potential (15). 
Due to the unavoidable variability of human material, differ- 
ences are noted in the kinetics and extent of the T cell repopu- 
lation observed after in vitro intrathymic transfer of precursor 
cells. Also, in some cases, precursor cells sorted from one given 
donor were unable to reconstitute a particular thymus, at any 
number of transferred ceils, suggesting that allogeneic recon- 
stitution may be dependent upon yet unknown compatibility 
requirements. These constraints may be similar to those ge- 
netically defined factors enforcing host resistance to donor 
hematolymphoid transplants, even in irradiated hosts (16). 
However, despite these limitations, >40 successful T cell 
repopulations have been observed after CD34 + cell transfer. 
In animal models, experimental chimeras have been in- 
strumental at elucidating the complex cell interactions in- 
volved in the ontogeny of the thymus (17). Defining the ability 
of potential progenitors to differentiate into T lymphocytes 
is an important step towards the characterization and 
purification of human hematopoietic stem ceils, as well as 
in the study of positive selection (MHC restriction) and nega- 
tive selection (self-tolerance) of developing human thymo- 
cytes from genotypicaily defined precursors in contact with 
genotypically defined thymic stroma. Also, this system may 
allow studies towards the elucidation of potential human bone 
marrow targets of pathogenic human lymphotropic viruses 
such as HIV, HTLV, and EBV. 
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